MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Thursday, June 23, 2016

12:00pm-1:30pm
Incidence and etiologies of pediatric asterixis

B.R. Aravamuthan, J.L. Waugh (Boston, MA, USA)

Pediatric movement disorder  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Incidence of fragility fractures in people with parkinsonism [PwP] – A 5 year retrospective observational study

S. Aithal, C. Thomas, S. Raha, H. Shukla, L. Ebenezer, R. Sequeria, B. Mohamed (Caerphilly, United Kingdom)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Influence of treadmill gait training with additional load on motor function, postural instability and history of falls for individuals with Parkinson’s disease: A randomized clinical trial

L.C.L. Trigueiro, A.V.C. Sousa, G.L. Gama, T.S. Ribeiro, L.G.L.M. Ferreira, C.R. Simão, É.R.V.P. Galvão, E.M.G.S. Silva, C.G. Júnior, A.R.R. Lindquist (Natal, Brazil)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Inhibition of cathepsin D enhances the autophagy lysosome pathway dysfunction and α-synuclein aggregation in experimental parkinsonism

L. Li, Y.P. Yang, L. Gao, Y. Song, Z. Liang (Suzhou, People's Republic of China)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Inhibition of glucosylceramide synthase reduces pathology and improves cognition in synucleinopathy murine models

L. Shihabuddin, C. Viel, J. Clarke, H. Park, J.C. Dodge, J. Marshall, B. Wang, S.H. Cheng, S.P. Sardi (Framingham, MA, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Interdisciplinary allied health care in a southern Brazil service

V.L. Israel, B. Yamaguchi, V.L. Israel (Curitiba, Brazil)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
International differences in the baseline characteristics and clinical management of cervical dystonia patients presenting for botulinum toxin treatment in routine practice

D. Charles, T.M. Chung, V.P. Misra, C. Colosimo, S. Om, P. Maisonobe (Nashville, TN, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Investigating the plastic effects of rapid paired associative stimulation in dystonia

V.F.M. Ramos, P. Srivanitchapoom, S. Pandey, A. Holmes, S. Kukke, R. Paine, N. Thirugnanasanbandam, N. Dang, M. Hallett (Bethesda, MD, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Investigation of head tremor in cervical dystonia: Novel application of virtual reality head mounted display, the oculus rift

I.M. Beiser, B. Quinlivan, E. McGovern, L.J. Williams, S. Narasimham, O. Killian, R. Beck, G. Colvert, S. O'Riordan, J.S. Butler, R.B. Reilly, M. Hutchinson (Dublin, Ireland)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Investigation of the influence of the parieto-premotor network on the motor cortex in writer’s cramp using transcranial magnetic stimulation

J.E. Park, P. Mathew, M. Villegas, P. Srivanitchapoom, M. Hallett (Bethesda, MD, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 53
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley